22
No competing interests have been declared. Unfortunately samples from botulism horses were unavailable for this part of the study. 150 QFWB was done as previously described [12, 13] . Briefly, protein was extracted in RIPA 151 buffer h containing 0.1% protease inhibitor cocktail i from EGS (n=6) and control (n=6) horse 152 CCG and the protein concentration determined using the Micro BCA Assay j . CCG proteins 153 (20μg load) were separated by SDS-polyacrylamide gel electrophoresis on 4-12% precast 154 NuPage BisTris gradient gels k and then transferred to PVDF membrane using an iBlot 2 fast 155 transfer device k . The membranes were then blocked using Odyssey blocking buffer l and 156 incubated with primary antibodies according to manufacturers' instructions ( Table 2) . 157 Secondary antibodies (goat anti-rabbit IRDye 680 and donkey anti-mouse IRDye 680 l ) were 158 added according to manufacturers' instructions. Blots were imaged using an Odyssey Infrared 159 7 Imaging System l . Scan resolution of the instrument ranges from 21 to 339 µm, and blots were 160 imaged at 169 µm. Quantification was performed on single channels with the analysis 161 software provided. Total protein stained gels were loaded in parallel with those used for 162 membrane transfer, to ensure equal sample loading, and were analysed using the Odyssey 163 Infrared Imaging system l as previously described [12] . 
Results
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There was no significant inter-group difference in age. The distribution and density of labelling for all three SNARE proteins in CCG neurons was 180 indistinguishable between control and botulism horses (Fig 2) . In these horses, many neurons 181 were unlabelled while others had faint punctate labelling confined to axons and to clusters of 182 granules within soma. CCG neurons from EGS horses had variable intensity and distribution 183 8 of labelling, but there was increased intensity of labelling for all three proteins compared with 184 botulism and control horses. The increased labelling of EGS neurons was most marked for 185 Syb. EGS neurons had increased labelling throughout the soma or predominantly in the 186 peripheral perikaryon, and frequently extending into proximal axons (Fig 2) . Occasional EGS 187 neurons had faint labelling that was indistinguishable from that of botulism and control The increased expression of SNARE proteins in neuronal perikarya in EGS, and not in 251 botulism, is inconsistent with the hypothesis that BoNT/C causes EGS. Indeed, 252 immunoreactivity of particular intact SNARE proteins at neuromuscular junctions is reduced 253 following proteolytic cleavage by particular BoNTs [26, 27] 
